Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Glabellar Lines”

79 trials

Showing 20 of 79 results

Large-scale testing (Phase 3)Study completedNCT02450526
What this trial is testing

Dysport in the Treatment of Glabellar Lines in Chinese Subjects

Who this might be right for
Glabellar Lines
Ipsen 520
Large-scale testing (Phase 3)Study completedNCT05380154
What this trial is testing

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 500
Testing effectiveness (Phase 2)Study completedNCT01485601
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 121
Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Large-scale testing (Phase 3)Study completedNCT05059587
What this trial is testing

Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 318
Large-scale testing (Phase 3)Study completedNCT01791920
What this trial is testing

To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines

Who this might be right for
Skin Aging
Hugel 262
Large-scale testing (Phase 3)Study completedNCT06585696
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Who this might be right for
Glabellar Frown Lines
Cutia Therapeutics（Wuxi）Co.,Ltd 554
Large-scale testing (Phase 3)Looking for participantsNCT06937944
What this trial is testing

Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd. 669
Large-scale testing (Phase 3)UnknownNCT05801146
What this trial is testing

Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Hugel 272
Large-scale testing (Phase 3)Study completedNCT03216408
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Medy-Tox 504
Large-scale testing (Phase 3)Study completedNCT06946160
What this trial is testing

A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar LinesGlabellar Frown Lines
Espad Pharmed 146
Very early researchUnknownNCT05083286
What this trial is testing

Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)UnknownNCT05623410
What this trial is testing

Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
ATGC Co., Ltd. 300
Post-approval studies (Phase 4)Study completedNCT01814670
What this trial is testing

Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines

Who this might be right for
Glabellar Rhytides
Allergan 185
Post-approval studies (Phase 4)Study completedNCT00856414
What this trial is testing

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Who this might be right for
Skin Aging
Allergan 45
Large-scale testing (Phase 3)Study completedNCT05804656
What this trial is testing

Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial

Who this might be right for
Glabellar Lines
CKD Bio Corporation 300
Large-scale testing (Phase 3)Not Yet RecruitingNCT07013279
What this trial is testing

Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Daewoong Pharmaceutical Co. LTD. 324
Early research (Phase 1)Study completedNCT06151561
What this trial is testing

Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
AbbVie 24
Testing effectiveness (Phase 2)Study completedNCT04143815
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 200
Testing effectiveness (Phase 2)Study completedNCT02184988
What this trial is testing

Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 352
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation